Emerging IL-12 Family Cytokines in the Fight Against Fungal Infections
Overview
Biology
Authors
Affiliations
Invasive fungal infections cause approximately 1.5 million deaths per year worldwide and are a growing threat to human health. Current anti-fungal therapies are often insufficient, therefore studies into host-pathogen interactions are critical for the development of novel therapies to improve mortality rates. Myeloid cells, such as macrophages and dendritic cells, express pattern recognition receptor (PRRs), which are important for fungal recognition. Engagement of these PRRs by fungal pathogens induces multiple cytokines, which in turn activate T effector responses. Interleukin (IL)-12 family members (IL-12p70, IL-23, IL-27 and IL-35) link innate immunity with the development of adaptive immunity and are also important for regulating T cell responses. IL-12 and IL-23 have established roles during anti-fungal immunity, whereas emerging roles for IL-27 and IL-35 have recently been reported. Here, we discuss the IL-12 family, focusing on IL-27 and IL-35 during anti-fungal immune responses to pathogens such as Candida and Aspergillus.
Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies.
Zhou J, Lu X, He R, Du Y, Zeng B, Feng L Sci China Life Sci. 2025; .
PMID: 40055278 DOI: 10.1007/s11427-024-2835-y.
IL-22 and IL-23 regulate the anticryptococcal response during infection.
Diniz-Lima I, Gomes A, Medeiros M, Guimaraes-de-Oliveira J, Ferreira-Dos-Santos I, da Silva-Junior E iScience. 2024; 27(10):111054.
PMID: 39635124 PMC: 11615251. DOI: 10.1016/j.isci.2024.111054.
Talapko J, Eric S, Mestrovic T, Stipetic M, Juzbasic M, Katalinic D Cancers (Basel). 2024; 16(17).
PMID: 39272855 PMC: 11394246. DOI: 10.3390/cancers16172997.
Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 Inhibitors.
Du S, Fang Y, Zhang W, Rao G Curr Med Chem. 2024; 31(20):2900-2920.
PMID: 38904160 DOI: 10.2174/0929867330666230324163414.
Dual function of fungi-derived cytokines in inflammatory bowel diseases: protection or inflammation.
Sharifinejad N, Mahmoudi E Gastroenterol Rep (Oxf). 2023; 11:goad068.
PMID: 38058517 PMC: 10697736. DOI: 10.1093/gastro/goad068.